[Skip to Navigation]
Sign In
Views 773
Citations 0
Comment & Response
May 27, 2021

Industry Payments to Medical Oncologists

Author Affiliations
  • 1Department of Pharmacy, Sendai City Medical Center, Sendai, Miyagi, Japan
  • 2Department of Breast Surgery, Jyoban Hospital of Tokiwa Foundation, Iwaki, Fukushima, Japan
  • 3Navitas Clinic Kawasaki, Kanagawa, Japan
JAMA Oncol. 2021;7(7):1072-1073. doi:10.1001/jamaoncol.2021.1287

To the Editor In their study published recently in JAMA Oncology, Tarras and colleagues1 analyzed honoraria and other payments provided to oncologists from 2014 to 2019 in the US. They demonstrated that financial conflicts of interest (FCOIs) have not been showing a decreasing trend even after inception of the Open Payments Program. In Japan, we initiated a similar transparency initiative with investigative journalists.2 From that standpoint, we would be grateful if the authors could respond to the following 2 concerns.

Add or change institution
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words